ID: ALA1632418

Max Phase: Preclinical

Molecular Formula: C10H12O3

Molecular Weight: 180.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CC(O)C#CC#C[C@@H](O)[C@H](C)O

Standard InChI:  InChI=1S/C10H12O3/c1-3-9(12)6-4-5-7-10(13)8(2)11/h3,8-13H,1H2,2H3/t8-,9?,10+/m0/s1

Standard InChI Key:  OBFINMGCIXVCBE-DJBFQZMMSA-N

Associated Targets(non-human)

Quinone oxidoreductase 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 180.20Molecular Weight (Monoisotopic): 180.0786AlogP: -0.72#Rotatable Bonds: 2
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.35CX Basic pKa: CX LogP: 0.32CX LogD: 0.32
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.39Np Likeness Score: 2.80

References

1. Shin D, Yang JE, Lee SB, Nho CW..  (2010)  SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities.,  20  (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066]

Source